Aleix Prat takes on the role of Chair of the Advisory Board at ONA Therapeutics
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a post on LinkedIn:
“Drug Discovery News!
Thrilled to take on the role of Chair of the Advisory Board at ONA Therapeutics, joining an outstanding team dedicated to developing first-in-class ADC therapies for aggressive cancers.
In collaboration with Roger Gomis, I have identified the target of ONA-255 and functionally validating it, working alongside the expert team at Ona led by Valerie Vanhooren (CoFounder and CEO).
This next-generation ADC has the potential to transform treatment for breast, gastric, and other solid tumors, and is now advancing toward clinical trials by the end of 2025.
With the addition of Jutta Amersdorffer (CMO) and Stephane Durant Des Aulnois (CFO) to Ona’s leadership team, we are accelerating the transition from groundbreaking science to impactful therapies for patients.
Innovative biology, real-world patient insights, and precision oncology are at the core of our approach.
Stay tuned – more exciting news are coming very soon!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023